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The adaptive immune system has been the core of immunology for the past century, as
immunologists have been primarily focused on understanding the basis for adaptive immu-
nity for the better part of this time. Immunological thought has undergone an evolution with
regard to our understanding as the complexity of the cells and the molecules of the system
became elucidated. The original immunologists performed their experiments with whole
animals (or humans), and for the most part they were focused on observing what happens
when a foreign substance is introduced into the body. However, since Burnet formulated
his clonal selection theory we have witnessed reductionist science focused ﬁrst on cell
populations, then individual cells and ﬁnally on molecules, in our quests to learn how
the system works. This review is the ﬁrst part of a chronology of our evolution toward a
molecular understanding of adaptive immunity.
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INTRODUCTION: THE LEGACY OF BURNET
The term adaptive immunity is usually reserved for that type of
immunity that adjusts in order to respond to an invading microbe,
i.e., it adapts. A synonym that has also been used is “acquired”
immunity, which is to say that it is different from “innate” or
inborn immunity. Adaptive immunity carries with it the conno-
tation of a heightened response to the re-exposure to an antigen
experienced previously. This we call immunological memory. It
is now recognized and well accepted that lymphocytes are the
cells responsible for adaptive immunity, and that the two major
types of lymphocytes, B cells and T cells, are both active par-
ticipants. The phenomenon of immunological memory depends
upon speciﬁcity of antigen recognition, as well as speciﬁcity of the
immunological response. As such, adaptive immunity explains
why vaccination is effective in preventing infectious diseases, and
thus is the essence of immunity, deﬁned as the exemption from
disease.
When trying to understand any biological phenomenon it is
often helpful to take a scholarly approach and delve into the past
history of thought and experimental data that have been brought
to bear on the problem. In this instance a logical starting point
is the discussion of “The Facts of Immunity” as laid down by Sir
Macfarlane Burnet in the third chapter of his seminal monograph
of the Abraham Flexner Lectures that he gave at Vanderbilt Uni-
versity in 1958, entitled “The Clonal selection Theory of Acquired
Immunity” (Burnet, 1959).
Burnet stated:
“The facts of immunity that I want to summarize are those which
seem most relevant to any attempt to look at the immune responses
as a part of a general biological picture.” They can be listed as
follows:
1. The physical nature of the populations of reactive globulin
molecules in a typical antiserum.
2. The differences, quantitative and qualitative, between primary
and secondary responses.
3. The lack of immunological reactivity to body components and
the related phenomenon of tolerance.
4. The qualitative types of immune response (i.e., cellular vs.
humoral).
5. Congenital agammaglobulinemia.
6. The part played by mesenchymal cells, particularly those of the
lymphoid series in immune reactions.
Of the nature of the reactive globulin molecules, considerable
progress had already been made in the ﬁrst half of the twentieth
century by the time of Burnet’s lectures (Edelman, 1959; Porter,
1959). Now, 50 years later, we know that antibody activity is ascrib-
able to immunoglobulin (Ig) molecules, which are identiﬁable in
the sera of all vertebrates, and in mammals are comprised of ﬁve
classes or isotypes, designated IgM, IgD, IgG, IgA, and IgE. Also,
as a result of the progress made in the second half of the twen-
tieth century, we know that Burnet’s theory of clonal selection is
correct, each Ig molecule is the product of a single B cell, which
differentiates into an Ig producing plasma cell (Fagraeus, 1948).
With regard to the differences between primary and secondary
immune responses, as summarized by Burnet,“A particularly clear
example is that obtained with staphylococcal toxoid in early work
(Burnet, 1940), where the primary response is slow and of low titer,
the secondary one rapid and rising almost logarithmically to a higher
titer.” We now know that the major difference accounting for the
rapidity of the secondary response compared with the primary
response, is owing to the proliferative expansion of the antigen-
selected clones of cells during the primary response, as initially
proposed by Burnet (Burnet, 1957, 1959). As to the qualitative dif-
ferences between the primary and secondary responses, we also
know that in the process of responding to the initial primary
exposure to antigen the B cells undergo a differentiative process
www.frontiersin.org December 2012 | Volume 3 | Article 369 | 1
“ﬁmmu-03-00369” — 2012/12/4 — 20:41 — page 2 — #2
Smith Understanding adaptive immunity – part I
to become “memory” B cells, which has now been explained at
the molecular level by genetic changes of recombination of the Ig
genes (Hozumi and Tonegawa, 1976), thereby accounting for iso-
type switching, and somatic hypermutation that accounts for the
phenomenonof afﬁnitymaturation (Bernard et al., 1978; Seidman
et al., 1978).
Thus, for the past 30 years we have known what happens as
a consequence of the primary antigenic stimulation, but we have
only recently begun to unravel the secrets of exactly how these
differentiative cellular changes take place at the molecular level,
and what the molecular signals are that dictate them. Initially, it
was assumed that antigen binding to surface Ig furnished all of the
molecular signals necessary, in that after antigen selection, B cell
proliferation ensues and precedes B cell differentiation. However,
we are now aware that there are additional molecular ligand-
receptor mechanisms that orchestrate these complicated cellular
changes. It follows that it is axiomatic that B cell proliferation and
differentiation are not simply pre-programmed changes that are
only intrinsic to B cells and not other types of cells.
One crucial aspect of Burnet’s view of immunity that still
had to be developed concerned the cellular immune response as
compared with humoral immunity. By the time that Burnet for-
mulated his theory,Medawar (1944) had shown that skin allografts
prompt a remarkable rejection reaction with graft-inﬁltrative
round inﬂammatory cells, and Chase (1945) had shown that it
is possible to transfer cutaneous delayed-type hypersensitivity
(DTH) to tuberculin with cells but not sera. Moreover, Bruton
(1952) had reported a child with agammaglobulinemia who was
unable to produce antibodies, and thus had great difﬁculty with
bacterial infections, but had no difﬁculty recovering from viral
infections.
Burnet ﬁrst proposed that lymphocytes are the cells responsible
for immunity (Burnet, 1957), and in his more extensive volume
(Burnet, 1959), he summarized the available data indicating that
there are at least three types of immune reactions:
1. Classical antibody responses
2. Hay-fever type responses
3. Tuberculin type responses
The ﬁrst two types he was able to convincingly attribute to Ig
molecules. However, the third type was problematic, in that
“Type (3) differs sharply in that there is no evidence that any
circulating antibody is produced” (Burnet, 1959). Burnet went
on to discuss that perhaps lymphocytes might be responsi-
ble for these cellular reactions, but he was still unsure of the
origin of lymphoid cells, and he speculated that perhaps all
mesenchymal cells were interchangeable, including lymphocytes,
monocytes/macrophages, plasma cells, and even ﬁbroblasts. There
seemed to be no controversy that plasma cells were the source of
antibody molecules (Fagraeus, 1948), but there was a lack of con-
vincing evidence of the interchangeability of each of these cells,
especially as to whether lymphocytes could become plasma cells.
Because of the uncertainty of the cellular origins of immune
responses, both humoral as well as cellular, Burnet could not fur-
nish experimental support for his clonal selection theory. In his
monograph, Burnet comes to the following conclusion:
“Only by the use of a pure clone technique of tissue culture, which
allows mesenchymal cells to retain full functional activity, would we
be likely to ﬁnd an answer. The clonal selection hypothesis would be
completely validated if it could be shown that single cells from a non-
immune animal gave rise to clones, each cell of which under proper
physiological conditions contained, or could liberate, antibody-type
globulin of a single pattern” (Burnet, 1959).
Of course, now with the advantage of hindsight, we know
the answers to the questions posed by Burnet. However, it took
another two decades to acquire the experimental data to prove the
clonal selection theory, so as to make it the Clonal Selection Law
of immunology. Moreover, Burnet was prescient in his prediction
that only the capacity to develop pure clones of functional cells
would make it possible.
LYMPHOCYTES: THE CELLULAR BASIS FOR IMMUNITY
The initial breakthrough was supplied only 1 year later by Nowell
(1960), who made the serendipitous discovery that a plant lectin
extracted from the kidney bean, phytohemagglutinin (PHA), had
the remarkable capacity to promote a morphological change in
small round resting human lymphocytes to one in which the
cells resembled immature leukemic blast cells, which became
termed lymphocyte “blastic transformation.” Moreover, follow-
ing this blastic transformation the cells underwent mitosis and
cytokinesis. These ﬁndings were truly seminal, because prior to
Nowell’s discovery, lymphocytes were described in textbooks as
terminally differentiated, end-stage cells, incapable of self-renewal.
Soon thereafter, Gowans et al. (1962) demonstrated that small
lymphocytes would undergo proliferation in vivo after antigenic
stimulation and give rise to circulating antibodies. Other reports
followed soon thereafter that extended the phenomenon to speciﬁc
antigen in vitro (Hirschhorn et al., 1963; Bach and Hirschhorn,
1964; Bain and Lowenstein, 1964). Accordingly, Burnet’s prophecy
that antigen selected lymphocytes could undergo proliferative
clonal expansion became a reality.
Also at this time, the capacity to visualize and enumerate
antibody-forming cells (AFCs) in vitro was ﬁrst reported by Neils
Jerne together with Al Nordin and Claudia Henry (Jerne and
Nordin, 1963). This technique, which came to be called the Jerne
plaque assay, employed a source of lymphocytes from an animal
immunized with sheep red blood cells (SRBCs), and a source of
complement, which was supplied by using guinea pig sera. Thus,
splenocytes or lymph node cells from SRBC-immunized rabbits
or mice could be mixed with SRBCs and soft agar, and placed in
Petri dishes, followedby the addition of complement,whichwould
facilitate antibody-mediated lysis of the SRBCs, thereby forming a
clear “plaque” against the homogeneous red background formed
by the SRBCs. Each clear plaque could be observed under the
microscope to contain a single central lymphoid cell, thus provid-
ing the ﬁrst evidence that individual lymphocytes could give rise
to cells that secrete antibody molecules. However, these data did
not actually prove Burnet’s theory, in that the antibody molecules
secreted by single cells still had to be shown to be “monoclonal” or
identical individual Ig molecules.
In addition, the thymus had intrigued immunologists for some
time, but experiments removing the thymus from animals failed
to yield any immunological consequences, so that it was not clear
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whether this curious lymphoid organ played a role or not in the
immune system. Since newborns were immunologically naive,
Jacques Miller reasoned that the thymus might play a role in
lymphocyte development, and thus he conjectured that “neona-
tal thymectomy might be associated with some detectable effect on
the maturation of immunological faculty” (Miller, 1962).
Accordingly, Miller devised a method to thymectomize mice
within the ﬁrst 3 days of life (day 3 thymectomy; d3Tx). He
found that such d3Tx mice grew normally during the ﬁrst month,
but thereafter suffered from “runting disease” very similar to
graft vs. host disease (GvHD), “characterized by progressive weight
loss, lethargy, rufﬂed fur, humped posture and diarrhea” (Miller,
1962). Most mice succumbed before 3 months of age with lym-
phocytes invading multiple organs. Within the ﬁrst 6 weeks of
life, when the mice looked grossly normal, the d3Tx mice were
found to have a severe peripheral lymphopenia and undevel-
oped secondary lymphoid tissues. In addition, these mice were
markedly immunocompromised, in that both skin allografts as
well as xenografts went unrejected, and d3Tx mice failed to pro-
duce antibody agglutinin activity in response to common bacterial
antigens. Accordingly, this was the ﬁrst inkling that the thymus
was important for the development of immunity, and Miller cor-
rectly concluded that “during very early life, the thymus produces
the progenitors of immunocompetent cells whichmature andmigrate
to other sites.” However, the cause of the runting disease that led
to the premature demise of neonatally thymectomized mice went
unexplored and unexplained.
In studies examining a secondary immune response of rabbits
to the injection of a small molecular hapten coupled to a large
protein carrier, Ovary and Benacerraf (1963) clearly showed that
antibodies reactive with the hapten are increased only when the
same carrier protein is used for the secondary stimulus as for the
ﬁrst injection. Also, if only the carrier protein is used for the second
injection, an anamnestic response to the hapten does not occur.
Eventually, this came to be called the “carrier effect,” although the
basis for this phenomenon went unexplained.
Against this background the work of Cooper et al. (1965, 1966)
in the chicken was seminal in deﬁning two separate and distinct
immune pathways. The avian Bursa of Fabricius, a lymphocyte-
rich outpouching of the gastrointestinal tract much like the
appendix, had been discovered serendipitously to be origin of
precursors of AFCs (Glick et al., 1956). Thus, neonatal bursec-
tomy led to the avian equivalent of Bruton’s agammaglobulinemia
and the incapacity of producing antibody activity in response to
immunization.
Accordingly, Cooper subjected newly hatched chickens to bur-
sectomy, thymectomy or both, and then traced their development
of secondary lymphoid organs, as well as their capacities to gen-
erate antibodies or to reject skin grafts. He found that like in
mammals, “thymus-dependent development is represented mor-
phologically by the small lymphocytes in the circulation, and the
white pulp-type development of the tissues. . . . . .and is basic to the
ontogenesis of cellular immunity: graft vs. host responses, delayed
hypersensitivity and homograft rejection. By comparison, “bursa-
dependent development is represented by the larger lymphocytes
of the germinal centers and the plasma cells, and functionally
by the immunoglobulins.” It was also noted by Cooper and his
team that although neonatally thymectomized and irradiated
chickens had normal circulating IgM and IgG levels, they only
produced about half as much speciﬁc antibody responses to
some, but not all antigens (Cooper et al., 1965). Such antigens
were subsequently termed thymus-dependent or T-dependent
antigens.
Thus, by 1965 adaptive antigen-speciﬁc immunity was estab-
lished to derive from small lymphocytes that originated in the
thymus, subsequently termed T cells, and in the bird in the bursa
of Fabricius, subsequently termed B cells. A prolonged search for
the mammalian equivalent of the avian bursa was negative, so that
the default tissue became the bone marrow, assumed to be the
source of antibody-forming mammalian B cells, and fortuitously
also beginning with the letter B.
The year 1965 was also the year of the ﬁrst reports of antigen-
non-speciﬁc mitogenic activities produced by alloantigen-
stimulated leukocytes. Two groups reported simultaneously that
allogeneic mixed lymphocyte cultures produced “blastogenic fac-
tors” (Gordon and MaclLean, 1965; Kasakura and Lowenstein,
1965). Also, antiviral activity similar to interferon was found
in mitogen-stimulated leukocyte culture supernatants (Wheelock,
1965). These ﬁndings were considered anomalous by most immu-
nologists, because it was unclear how such antigen-non-speciﬁc
activities, subsequently termed lymphokines, could participate in
antigen-speciﬁc adaptive immunity. From this beginning, lym-
phokines were relegated to a secondary role, thought simply as
amplifying antigen-initiated processes that were already ongo-
ing. No one anticipated that lymphokines might be essential for
adaptive immune responses to speciﬁc antigen, and crucial for
immunoregulation.
IMMUNE RESPONSE GENES AND CELLULAR COOPERATION
By far, some of the most exciting and intriguing ﬁndings of the
1960s were the reports by Baruj Benacerraf and his team of the
genetic control of immune responses to synthetic polypeptide
antigens in guinea pigs (Kantor et al., 1963; Levine et al., 1963;
Green et al., 1966), and the conﬁrmation and extension of these
ﬁndings to inbred mouse strains by Hugh McDevitt and his group,
who demonstrated that the genes in control were linked to those
of the major histocompatibility complex (MHC; McDevitt and
Tyan, 1968; McDevitt and Chinitz, 1969). However, exactly how
this large and complex gene locus regulated the immune response
remained totally obscure.
One clue was provided by Henry Claman’s group, who ﬁrst
showed that thymocytes and bone marrow derived cells cooper-
ated in the production of antibodies (Claman et al., 1966). They
took advantage of a system whereby potential immunocompe-
tent cells are transferred to irradiated hosts, then immunized
with SRBCs as antigen. They found that splenocytes were capa-
ble of producing foci of AFCs, but neither thymocytes nor bone
marrow cells alone could do so. However, a combination of
thymocytes + bone marrow cells were very active. “The sim-
plest interpretation is that one cell population contains cells capable
of making antibody (“effector cells”), but only in the presence of
(“auxiliary cells”). However, their data did not allow them to dis-
criminate the former vs. the latter. Conclusive experiments by
Jacques Miller and George Mitchel using adult thymectomized,
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irradiated bone marrow-protected mice showed that “AFC pre-
cursors were derived from bone marrow, while the role of thymus
cells or of thoracic duct lymphocytes (TDL) is to inﬂuence in some
way the differentiation of AFC precursors in response to antigen”
(Miller and Mitchell, 1969).
Subsequently, several technical ﬁndings advanced the capacity
of immunologists to study the immune response. Up until the late
1960s the immune response, of necessity could only be studied
in vivo, either in animals or humans. Mishell and Dutton (1967)
made possible the analysis of the entire immune response in vitro
by mixing naïve mouse splenocytes with SRBCs in culture for sev-
eral days to promote a primary immune response, which they then
quantiﬁed using a Jerne plaque assay. This facilitated examination
of several aspects of the immune response that had heretofore
been hidden in the proverbial in vivo “black box.” In particular it
allowed the direct observation of Burnet’s prediction of the prolif-
erative expansion of antigen-reactive clones (Dutton and Mishell,
1967). In addition, it also led to a dissection of the cells involved,
and it was readily shown that macrophages are required for anti-
body formation to SRBCs by lymphocytes (Mosier, 1967). Also,
in the words of Don Mosier, “It appears that in the mouse spleen,
production of antibody to sheep erythrocytes involves both antigen
phagocytosis by macrophages and macrophage lymphocyte interac-
tion, both processes being essential for development of lymphoid cells
releasing hemolytic antibody.”
Also, in a prescient report, Emil Unanue and Brigitte Askonas
showed convincingly using radiolabeled protein antigen that
“immunogenicity of live macrophages persisted relatively unaltered
for prolonged periods of time (as long as two weeks) and appeared
to be associated with only a small percentage of antigen held by the
cell in a form where it was protected from rapid breakdown and
elimination” (Unanue and Askonas, 1968).
Theodore Brunner’s team developed a radiolabeled 51Chrom-
ium-release assay that enabled the quantiﬁcation of direct cell-
mediated lysis (CML) of target cells, so that one could readily
identify and quantify the amounts of lysis mediated by one cell
population vs. another (Brunner et al., 1968). This assay extended
the antigen-activation of lymphocyte proliferation to the capacity
to monitor effector properties of cell-mediated antigen-speciﬁc
adaptive immune reactivity in vitro, thus greatly facilitating the
analysis of DTH, allograft rejection and GvHD.
Soon thereafter, using living cells rather than ﬁxed or frozen
cells, and using ﬂuorescent-labeled antisera reactive with the theta
(θ) antigen, which was known to be expressed preferentially by
thymocytes and brain, Martin Raff identiﬁed θ-positive cells in
a subset of murine peripheral secondary lymphoid tissues, and a
reciprocal population of cells that were reactive with ﬂuorescent-
labeled anti-Ig (Raff, 1969; Raff et al., 1970). Pernis et al. (1970)
conﬁrmed and extended the expression of surface Ig on a subpop-
ulation of rabbit lymphocytes, and speculated that this surface Ig
could be the antigen receptors predicted by Burnet.
Martin Raff immediately tested the role of θ+ splenocytes
(T cells) in a secondary humoral immune response in hapten-
carrier primedmice (Raff, 1970). The experimental setup included
adult mice immunized with the hapten 4-hydroxy-3-iodo-5-
nitrophenyl acetic acid (NIP) coupled to the carrier bovine serum
albumin (BSA). Splenocytes from these mice were harvested 8–12
weeks after immunization, treated or not with anti-θ and guinea
pig sera as a source of complement, and then injected into syn-
geneic recipients previously irradiated with 600 rad. The following
day the recipients were immunized with NIP-BSA, and then tested
for circulating antibodies 10 days later. The results indicated that
theT cells are“helper”cells, responding to the carrier determinants
on BSA, whereas non-θ+ cells are the cells responsible for produc-
ing antibodies reactive with the hapten NIP. These ﬁndings were
also conﬁrmed and extended to the total in vitro immunization
system by Schimpl and Wecker (1970).
Despite these new ﬁndings, the role of thymocytes and thymic-
dependent cells in immunity was still obscure, leading Jerne just
1 year later to propose that “in the primary lymphoid organs, e.g.
in the thymus, the proliferation of lymphocytes. . . . leads to the selec-
tion of mutant cells expressing v-genes that have been modiﬁed by
spontaneous random mutation.” (Jerne, 1971). He was partially
correct about somatic mutation as responsible for the creation
of antibody-antigen binding diversity, but totally wrong about
thymocytes as precursors of AFCs.
T CELL “HELP” AND HELPER FACTORS
Miller and Sprent (1971) were uniquely poised to perform adop-
tive transfer experiments to determine whether primed T cells and
primedAFC precursors both possessed“memory,” and cooperated
to produce a secondary immune response. To ensure complete
depletion of thymus-derived cells these investigators employed a
system of transferring TDL from antigen-primed mice to irradi-
ated recipients. To test whether primed T cells were required, the
thoracic duct cells were treated with anti-H2 sera that they had
shown would eliminate virtually 100% of the T cells. Anti-θ sera
were also used, but were found to only partially deplete T cells.
These cells were then adoptively transferred to neonatally thymec-
tomized mice: the antibody responses were lower by 1 log10 when
T-depleted TDL were transferred. Moreover, primed B cells were
also required in these adoptive transfer experiments, leading to the
conclusion that “memory is a property that can be linked to both B
cells and T cells.” (Miller and Sprent, 1971).
Given these ﬁndings, a series of experiments reported byAvrion
Mitchison were seminal in a ﬁeld that was to become obsessed
with the question as to the molecular mechanism(s) of how T
cells recognize antigens when they “help” antibody production,
as well as the molecular mechanism(s) of the “help.” Mitchi-
son’s experiments on the secondary immune responses of mice
to immunization with hapten-carrier conjugates led him to con-
clude that the helper T cells recognize carrier determinants and
the AFC precursors recognize either the hapten or other carrier
determinants (Mitchison, 1971). He speculated that there was “the
possibility of an antigen bridge linking the receptor (presumably a
normal Ig molecule) on the AFC precursor with another receptor
(IgX) on the thymus derived cell.” This concept came to be termed
“linked recognition,” and led to a familiar schematic diagram of
a B cell-antigen-T cell linkage presented at virtually all scientiﬁc
meetings thereafter. Another term subsequently used for this func-
tion became known as “cognate recognition,” which emphasized
the physical interaction between the AFC and the T cell, as well as
the presumed molecular similarity between the B cell and T cell
antigen recognition molecules.
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Thus, the stage was set for the question that became the “holy
grail” of immunology for the next decade, the nature of the T cell
antigen receptor, which became abbreviated to simply the T cell
receptor (TCR). Many of the most accomplished and prestigious
research groups were attracted to the quest. Moreover, the focus
of many immunologists also became the question as to how T cell
“recognition” of antigen led to the apparent required T cell “help”
provided to B cells that promoted antibody formation, as well as
the molecular mechanism(s) responsible. The solutions to these
questions consequently became intertwined.
Confounding these issues was the growing awareness that
macrophages also seemed to play a role in the “help” that B
cells required. It had also been shown that T cells needed “help”
from macrophages to proliferate in response to stimulation by
speciﬁc antigens and low concentrations of non-speciﬁc mito-
gens, such as PHA (Oppenheim et al., 1968). Accordingly, it was
a logical next step to ask the question as to whether a soluble
macrophage product might serve to replace the necessity of actual
macrophages themselves. Bach et al. (1970) presented evidence
that media conditioned by “an adherent cell population-enriched
in macrophages” could substitute for macrophages allowing puri-
ﬁed lymphocytes to proliferate in response to soluble protein
antigens or to allogeneic lymphocytes. They speculated that the
macrophages produced a factor that they termed “conditioned
medium reconstituting factor-CMRF” that potentiated in vitro
lymphocyte reactivity. The presumption was that the CMRF
was produced by macrophages but worked its effects on the
lymphocytes, amplifying their reaction to speciﬁc antigens.
Simultaneously, Richard Dutton and his group reported very
similar results analyzing the generation of AFCs using their
“Mishell–Dutton assay.” Thus, following up Mosier’s observation
that macrophages are required for the generation of AFCs reactive
with SRBCs in vitro, they found that conditioned media from 24 h
cultures of glass-adherent cells, incubated with or without SRBCs,
could substitute for macrophages in permitting the non-attached
lymphocytes to generate AFCs (Dutton et al., 1970; Hoffman and
Dutton, 1971). One other noteworthy aspect about the Mishell–
Dutton in vitroAFC assay was its dependence on“optimal batches”
of fetal calf sera (FCS) to observe any AFCs at all.
Soon thereafter, Igal Gerry working with Richard Gershon and
ByronWaksman reported a series of experiments that showed that
glass adherent cells released a mitogenic activity that enhanced the
proliferation of murine thymocytes as well as puriﬁed peripheral
T cells when stimulated by PHA (Gery and Waksman, 1972; Gery
et al., 1972). They called this activity lymphocyte activating factor
(LAF), and showed that its activity increased when the adherent
cells are stimulated with bacterial lipopolysaccharide (LPS). As to
its mechanism of action, it was speculated that LAF was simply
a mitogen itself, like PHA. Alternatively, they wondered whether
LAF supplied some trace nutrients necessary for cellular prolifer-
ation, thereby simply facilitating a proliferative process that was
already initiated by the PHA. They referenced the earlier work
on mitogenic activities found in leukocyte and macrophage con-
ditioned media, but there was no way to ascertain whether the
activities were identical or not.
Following up their ﬁndings of the requirement for T cells in the
Mishell–Dutton assay, Schimpl and Wecker noted that allogeneic
but not syngeneic thymocytes could substitute for θ+ splenocytes.
They speculated that the strong alloantigenic stimulation of the
thymocytes might have prompted them to produce a “potenti-
ating factor,” similar to the leukocyte-derived blastogenic factor
described previously (Gordon and MaclLean, 1965; Kasakura
and Lowenstein, 1965), and the macrophage-derived activities
described independently by Bach and by Dutton, except now
they were speciﬁcally looking for activities derived from T cells,
not macrophages or just leukocytes. Using the Mishell–Dutton
assay system for the in vitro generation of AFCs, they related new
evidence that there might actually be two activities produced by
alloantigen-stimulated T cells; (1) a T cell expanding factor (TEF),
similar to the blastogenic factor described previously, and that
acted best if added early to the cultures, but also (2) a T cell replac-
ing factor (TRF), which acted best if added late to the cultures
(Schimpl and Wecker, 1972). They further speculated that the
TRF would act on B cells, facilitating their differentiation to AFCs,
and in the Mitchison linked-recognition model, the soluble TRF
would only be at work over a very short range, like a neurotrans-
mitter, and would only be capable of “helping” the B cell linked
to a T cell via an antigen bridge between their respective antigen
receptors. Thus, they covered all bases. Also, now it seemed pretty
clear that for an antibody response to a T-dependent antigen, three
distinct cells were required, B cells, T cells, and macrophages, and
that soluble activities were produced by both macrophages and T
cells that could replace the cells themselves.
T CELL SUPPRESSION AND IDIOTYPIC “NETWORKS”
Two additional concepts were introduced at about this time that
had tremendous inﬂuence on immunological thinking as well as
experiments for the next decade. Richard Gershon reported that
there were “suppressor T cells,” in addition to “helper T cells,”
and that these cells might be responsible for immunological tol-
erance (Gershon and Kondo, 1970, 1971; Gershon et al., 1972).
Moreover, these cells were antigen-speciﬁc and could be induced
by antigenic stimulation, so that the outcome of antigenic stim-
ulation, immunological activation or tolerance, depended upon
a balance between T cell help vs. T cell suppression. Many of
Gershon’s experiments were quite complex, involving thymec-
tomized, lethally irradiated, bone marrow reconstituted mice
that were subsequently immunized with large doses of SRBCs.
Moreover, in many of his experiments, cells were adoptively
transferred between serial recipients, which were also irradiated
and reconstituted with various cell populations. Even though
the experiments were complicated, his work gained credence
because it was preformed in vivo. However, the mechanisms
whereby these suppressor T cells functioned were obscured by
the proverbial in vivo black box. Gershon speculated that perhaps
they secreted a suppressive antigen-binding molecule, which he
termed IgY to distinguish it from Mitchison’s putative secreted
helper factor, IgX. The immunological community was very
receptive to Gershon’s concepts, because they promised ways
to manipulate the immune response therapeutically, either to
enhance or suppress it. Therefore, there was something in it for
everyone.
Neils Jerne’s “Idiotypic Network Hypothesis” is the other, very
highly inﬂuential concept introduced in the 1970s (Jerne, 1974,
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1976). To account for experimental observations that the antigen-
binding, v-region of antibody molecules, which he termed a
paratope, could itself serve as an antigen or a unique epitope
that could be recognized by other B cells and give rise to anti-
bodies reactive with them, the terminology of idiotopes and
idiotypes was introduced. Jerne proposed that the vastly diverse
population of antibody molecules in a normal individual rep-
resents a vast collection of antigens (idiotopes) by virtue of the
unique amino acid sequences of each v-region. Thus, “antibody
molecules can be recognized as well as recognize.” Jerne hypothe-
sized that prior to the introduction of an external antigen, the
concentration of each idiotope was low enough so that the sys-
tem displayed an “eigen” behavior, a mathematical-physics term
that is translated from the German as “self” behavior. Thus, Jerne
proposed that resulting from paratope–idiotope interaction, the
system achieves a dynamic steady state, as its elements interact
between themselves. However, with the introduction of a for-
eign epitope, the B cells recognizing it would be stimulated to
proliferate, thereby increasing the proportion of epitope-reactive
cells, which would then differentiate into high epitope-reactive
antibody producing plasma cells, ﬂooding the system with their
idiotopes. The net effect would be to markedly increase the con-
centration of the E-reactive idiotopes, which would exceed the
activation threshold of many more reactive B cells, leading to
the production of many anti-idiotopes. Ultimately, Jerne envi-
sioned that the growing network stimulated by the original epitope
would feed back to neutralize the response to the original foreign
epitope.
MHC RESTRICTION
One aspect of the immune system not considered by Jerne was the
nature of themolecules that T cells used to recognize antigens. Like
most others at the time, Jerne assumed that the TCR would also be
found to be an Ig-like molecule, so that he envisioned T cells and
B cells to be interchangeable from the standpoint of their antigen
recognition molecules. Moreover, there was no place in the net-
work hypothesis for Ir-genes as regulators of immune recognition.
According to Jerne, “Benacerraf and McDevitt regarded inescapable
the conclusion that there exists a class of molecules encoded by Ir-
genes, which are responsible for recognition of speciﬁcity at the
T cell level, and that these molecules are not immunoglobulins”
(Jerne, 1974).
In attempts to understand Ir-gene function, and shed light on
the nature of Ir gene products, David Katz and Baruj Benacerraf
took a genetic approach to examine the question as to whether
B cells and T cells needed to be histocompatible for the gen-
eration of AFCs in response to hapten (DNP)/carrier (keyhole
limpet hemocyanin, KLH) conjugates (Katz et al., 1973). They
used F1 hosts (A × B strains) as recipients of hapten-primed B
cells from one parent (e.g., A strain) and carrier-primed T cells
from the other parent (B strain), and found that only histocompat-
ible (syngeneic) combinations would cooperate to generate AFCs.
They then also performed similar experiments in vitro with sim-
ilar results. They speculated that the B cells might express an
MHC-encoded “acceptor” molecule that interacted with a simi-
lar MHC-derived molecule either secreted by, or expressed on the
surface of the T cell.
This report was followed soon afterward by a similar report
from Rosenthal and Shevach (1973) who studied the histocom-
patibility requirements of macrophages and T cells for speciﬁc
antigen-induced T cell proliferation. Using guinea pig cells, they
found that “efﬁcient interaction of macrophage associated antigen
and immunospeciﬁc T lymphocytes as measured by antigen-induced
lymphocyte proliferation, only occurs when the macrophages and T
cells are histocompatible (syngeneic). It is likely that this interac-
tion is mediated by histocompatibility antigens themselves, or by the
products of genes closely linked to the MHC.”
Accordingly, these reports established that Ir genes linked to
the MHC complex somehow were very important for T cell anti-
gen recognition. Whether it was necessary that MHC-encoded
molecules were expressed by all of the cells for a productive inter-
action to occur remained to be determined. However, it was
tantalizing to think that the MHC region actually coded for the
elusive TCR. In this regard, it is important to understand that the
genetic experiments done at the time indicated that the helper
effects on the generation of AFCs and on antigen-speciﬁc T cell
proliferation did not map to the traditional serologically-deﬁned
MHC-encodedmolecules. Instead, theymappedbetween the sero-
logical determinants in what was termed the MLC-derived locus,
that later became the I-region, or the Ir region, for immune
response region.
In the face of these ﬁndings, the reports by Zinkernagel and
Doherty (1974a,b), who studied the histocompatibility require-
ments for cytolytic T cells to recognize and kill lymphocyte
choriomeningitis virus (LCMV)-infected cells, were particularly
informative. These investigators found that cytolytic T lympho-
cytes (CTL) could only kill virus-infected target cells if they shared
MHC loci, and that the MHC-encoded determinants mapped to
the regions deﬁned serologically. To explain their results, they
proposed that T cells expressed two TCRs, one comprised of
and interactive with self MHC-encoded determinants on the tar-
get cell, and another reactive with virus-speciﬁed determinants
(non-self), vs. the one TCR hypothesis, in which only one TCR
reacted with either a virus-modiﬁed MHC-encoded molecule or
a combination of virus + MHC-encoded molecules, the so-called
“altered self” hypothesis. In follow-up studies of MHC restriction
of virus-speciﬁc cytotoxicity across the H-2 barrier, Zinkernagel
concluded:
“The results are compatible with the idea that T cells are spe-
ciﬁc for “altered self” or “altered alloantigen”, i.e., a complex of
cell surface marker and viral antigen. Alternatively, explained with
a dual recognition model, T cells may possess two independently,
clonally expressed receptors, a self-recognizer which is expressed for
one of the syngeneic or tolerated allogeneic K or D “self” mark-
ers, and an immunologically speciﬁc receptor for viral antigen.”
(Zinkernagel, 1976).
ANTIGEN-SPECIFIC HELPER AND SUPPRESSOR FACTORS
Given these ﬁndings against the background of the reports of
both macrophage-derived and T cell-derived “factors” found in
leukocyte conditioned media, investigators began searching for
soluble factors, of both “helper” and “suppressor” varieties, and
both antigen-speciﬁc as well as antigen-non-speciﬁc. Taussig and
Monro (1974) were among the ﬁrst investigators to identify an
Frontiers in Immunology | Immunological Memory December 2012 | Volume 3 | Article 369 | 6
“ﬁmmu-03-00369” — 2012/12/4 — 20:41 — page 7 — #7
Smith Understanding adaptive immunity – part I
antigen-speciﬁc T cell-derived “helper” factor that appeared to be
comprised in part by MHC-encoded molecules. They produced
their factor as follows: “T cells (from mice) primed in vivo by
speciﬁc antigen, were incubated together with antigen in vitro for
6-8 hours. The cells were then removed by centrifugation and the
supernatant, containing the T cell factor, (was) transferred together
with bone marrow cells and antigen into lethally irradiated, syn-
geneic recipients. After 14 days the direct plaque-forming cell (PFC)
response to the antigen in the spleens of the recipients was measured
and compared to controls receiving B cells and antigen but no factor,
or B cells with T cells and antigen.” In attempts to characterize the
helper factor, they found that the activity was removed with an
immunoadsorbent column prepared with anti-H-2d sera, but not
anti-H-2k or anti-Ig. Based on their ﬁndings, they suggested that
“the T cell factor is the soluble expression of the T cell receptor.”
Also at this time, Marc Feldmann used combined in vivo
and in vitro methods to generate supernatants for study (Feld-
mann and Basten, 1972; Feldmann, 1974). First, “activated T
cells” were generated by lethally irradiating mice (800–900 rad),
followed by injection intravenously (IV) with 108 syngeneic thy-
mocytes, and intraperitoneally (IP) with antigens emulsiﬁed in
Freund’s complete adjuvant. Then 6–7 days later, splenocytes
from these mice containing the “activated T cells” were cultured
together with antigen in the upper chamber of double-chambered
Marbrook–Diener ﬂasks. The ﬂuid in the lower compartment
was harvested after 40–48 h and termed “T cell supernatant.”
Feldmann described three different kinds of activities in these
supernatants. There was an “antigen-speciﬁc helper activity” that
enhanced the generation of AFCs. In the same supernatants
there was both an “antigen-non-speciﬁc helper activity” as well
as an “antigen-speciﬁc suppressor activity.” To make things even
more complicated, it was found that macrophages could abrogate
the suppressor activities. Moreover, both antigen-speciﬁc helper
and suppressor activities were absorbed by Sepharose beads con-
jugated with anti-mouse Ig, anti-κ-chain or anti-μ-chain sera.
Thus, in contrast to Taussig and Monro, Feldmann speculated
that his T cell-derived factors, both helper and suppressor, con-
tained an Ig molecule that he termed IgT. Moreover, it was
claimed that suppression by “speciﬁc factor,” which he attributed
to IgT-antigen complexes, depended upon direct interaction with
lymphocytes.
Tomio Tada’s laboratory used a somewhat different system to
examine the molecular mechanisms responsible for the suppres-
sion of anti-hapten speciﬁc antibody responses by T cells primed
with high doses of carrier proteins (Takemori and Tada, 1975).
Both thymocytes and splenocytes from carrier-primed mice were
isolated and sonicated. Cellular debris was removed by centrifu-
gation and the cell-free supernatants were tested for their effects
on the generation of AFCs by their IV administration to naïve
mice immunized concomitantly with hapten-carrier conjugate
together with pertussis vaccine as adjuvant. The extracts were
found to contain a suppressive factor that depressed the capac-
ity of the immunized mice to generate IgG antibody responses to
the hapten. The activity was antigen-speciﬁc for the carrier protein
used to produce the factor. Like the activity described by Taussig
and Monro, immunoadsorbent columns prepared with antisera
raised against the K-end of the MHC complex of the donor strain,
but not by anti-Ig removed the activity. Also, immunoadsorbents
madewith the carrier protein antigen also removed the suppressive
activity.
Thus, all of these reports were focused on these antigen-speciﬁc
factors because they hoped that these elusive factors could lead
to the molecular nature of the T cell antigen receptor. However,
because each laboratory used different methods to produce and
assay for their factor activities, the ﬁeld was chaotic.
T CELL SUBSETS
Inbred mouse strains became a very important resource for inves-
tigating genetic contributions to immunological reactions. In
particular, Lloyd Old’s group introduced the concept of the iden-
tiﬁcation of subsets of T cells with their description of the Ly
gene loci that speciﬁed discrete alloantigens expressed by func-
tionally distinct T cells (Boyse et al., 1968, 1971). It is noteworthy
that the use of congenic mouse strains to produce alloantisera
created very unique reagents available only to a few investigators
who had access to the special congenic mouse strains. Also, large
numbers of mice were required to produce only small volumes of
precious antisera that could be used only for critical experiments.
Edward Boyse investigated congenic mouse strains that differed at
only one genetic locus and raised antisera by immunizing across
reciprocal congenic mouse strains. The Ly-1 and Ly-2 gene loci,
on chromosomes 19 and 6, were found to specify alloantigens
expressed exclusively and invariably on mouse T cells. Moreover,
each locus was found to have alternative alleles that determined
the T cell surface antigens Ly-1.1 and Ly-1.2, and Ly-2.1 and Ly-
2.2, respectively. Thus, Pawel Kisielow, working with Boyse, ﬁrst
showed that subsets of peripheral T cells express distinct alleles of
Ly surface determinants (Kisielow et al., 1975). Previous reports
established that there appeared to be at least two functional T cell
subsets, one that proliferated to a large extent when stimulated by
alloantigens in an MLC, and another that possessed most of the
cytolytic activity (Cohen and Howe, 1973). Kisielow found that
splenocytes could be distinguished, in that approximately two-
third were Ly-1+ and possessed most of the proliferative capacity,
whereas approximately one-third were Ly-2+ and possessed most
of the cytolytic capacity.
These ﬁndingswere conﬁrmed and extended byHarveyCantor,
alsoworkingwith Boyse (Cantor andBoyse, 1975a,b), who showed
that there were actually three subclasses of peripheral T cells, in
that ∼50% expressed all three Ly antigens, 1, 2, and 3. These cells
were thought to function as precursors of the other two distinct
subclasses. They also showed that during the MLC, the function
of the Ly-1+ population to amplify the cytolytic function of the
Ly-2/3+ population, depended on Ia+ stimulator cells. In a subse-
quent report the T cell subclasses were studied after immunization
with SRBCs. Cells of the Ly-1+ subclass were found to provide
“helper activity” for the generation of both primary and secondary
AFCs. By comparison, cells of the Ly-23+ subclass were found to
suppress the generation of AFCs. Because cytolytic cells could not
be further separated or distinguished from suppressor cells, the
T cell cytotoxic/suppressor (Tc/s) terminology was introduced to
immunology for the ﬁrst time (Cantor et al., 1976).
Subsequently, McDevitt’s group produced evidence indicating
that a new region within the I-region of the MHC locus, which
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they termed I-J, coded for surface determinants found only on
suppressor T cells (Murphy et al., 1976). These ﬁndings depended
on antisera produced by congenic mouse strains that differed only
in very restricted areas within the I-region of the MHC locus.
Simultaneously, Tada’s group using similar strains and antisera,
reported data indicating that their carrier-speciﬁc suppressor fac-
tors contained determinants encoded by the I-J subregion (Tada
et al., 1976). Thus, all of these data resulted in provocative evi-
dence that genes within the MHC locus encoded molecules, some
surface and some apparently secreted, that were very important for
T cell regulation of immune responsiveness. Some of the encoded
molecules were expressed bymacrophages andB cells, while others
were expressed by T cells. However, the molecular nature of these
determinants and activities remained obscure.
Because each of the investigators used differentmethods to gen-
erate and test their various factor activities, the ﬁeld was deﬁnitely
complicated, especially as each investigator claimed different func-
tional attributes for their factor activities. Moreover, there was a
striking lack of attempts to purify the molecules responsible for
the various activities, so that molecular characterizations beyond
assaying for reactivity with various antisera were non-existent.
The difﬁculties inherent in the biochemical techniques available
for protein separation and puriﬁcation were part of the reasons
that biochemical characterizations of the various activities had
not been performed. At the time, the only available techniques
were molecular sieves that separated proteins based upon their
molecular sizes or charges. Polyacrylamide gel separation had
not yet been described, and high pressure liquid chromatogra-
phy (HPLC) also was not yet available. However, another, just as
important impediment was the lack of rapid quantitative assays
available for the activities, with many investigators dependent
only on in vivo assays, which made the determination of activities
in many fractions from biochemical separative columns virtually
impossible.
LYMPHOCYTE-CONDITIONED MEDIA
The only in vitro assays available to identify the molecules
responsible for the various activities that had been found in
leukocyte-conditioned media (Ly-CM) monitored one of three
functions; proliferation, antibody formation, and cell-mediated
cytotoxicity. Thus, it is noteworthy that Plate (1976) described a T
cell-derived soluble activity that could replace helper T cells in the
generation of CTL. However, she could not differentiate the CTL
helper activity from blastogenic factor, or the TRFs described by
Schimpl and Wecker or Taussig and Monro. Thus, based upon the
assays used, by 1976 there were descriptions of a myriad of soluble
activities in Ly-CM.
At about the same time, several investigators used repetitive
alloantigen stimulation to maintain antigen-reactive cells in cul-
ture for longer than just a few days. There were varied reports
of success ranging from 3 to 4 weeks to several months. H. Rob-
son McDonald working with Jean Charles Cerottini and Theodore
Brunner ﬁrst reported that it was possible to maintain murine
CTL in culture using weekly or bi-weekly repetitive alloantigen
stimulation for periods as long as 2 months (McDonald et al.,
1974). Svedmyr (1975) reported similar ﬁndings using human
MLCs. He was successful in maintaining cells for as long as four
months by re-stimulating them bi-weekly. Subsequently, Zivi Ben-
Sasson working with Ira Green showed that it was possible to
use soluble protein antigen-pulsed adherent cell monolayers to
repetitively stimulate guinea pig lymphocytes for periods of 2–5
weeks (Ben-Sasson et al., 1975). Dennert and De Rose (1976) used
similar procedures and repetitive murine MLCs to continuously
culture alloreactive cells for as long as nine months. Accordingly,
in a period of just a few years, investigators operating under the
dogma that speciﬁc antigen activated the proliferation of T cells,
found that T cells could be repetitively alloantigen-stimulated and
cultured for prolonged periods.
Against this background, a report by Doris Morgan working in
Robert Gallo’s lab serendipitously found that conditioned media
from PHA-stimulated human lymphocytes promoted the long-
term culture of human bone marrow T cells for periods as long
as 13 weeks (Morgan et al., 1976). These investigators had been
searching for a growth factor that could facilitate the growth of
human acute myeloid leukemia cells (AML), and had used PHA-
stimulated Ly-CM, because it had previously been reported to
be a source for granulocyte colony stimulating activity (G-CSA;
Cline and Golde, 1974). Because they had used bone marrow
as the cell source for their cultures, which was know to con-
tain immature precursor T cell cells, it was not clear whether
the cells grown were immature or mature T cells, in that they
had not demonstrated any physiological mature T cell function
(Morgan, 1988).
Initially, it looked as though the cultured cellsmight beEpstein–
Barr virus (EBV)-transformedBcells. However, experiments using
fresh rather than PHA-stimulated Ly-CM could not support long-
term T cell growth, and further tests indicated that >95% of the
cells formed erythrocyte rosettes (E-rosettes) with SRBCs, which
was the only marker known at the time for human T cells. More-
over, tests for myeloid markers were negative. Because PHA was
a known T cell mitogen, the most plausible hypothesis was that
the PHA in the Ly-CM itself was responsible. However, the use of
fresh media + PHA could not support long-term T cell growth.
Accordingly, the default hypothesis was that a soluble mitogenic
factor or activity secreted into the Ly-CM by the PHA-stimulated
cells might be responsible. In this regard, one is reminded of Peter
Nowell’s conjecture that perhaps PHA stimulation caused the cells
to secrete a soluble factor that actually provided the growth signal
for the cells (Nowell, 1960), as well as blastogenic factor (Gordon
and MaclLean, 1965; Kasakura and Lowenstein, 1965).
Additional experimentswere performedusing peripheral blood
mononuclear cells (PBMCs) as a source of the long-term T cell
cultures, thereby excluding the possibility that the cells selected
for growth in the Ly-CM were exclusively immature T cell pre-
cursors. For these studies, we collaborated with Ruscetti and
co-workers, and established that activation of the cultured T cells
with T cell mitogens resulted in the production of IFN activity, an
accepted functional characteristic of mature T cells as compared
with immature T cells (Ruscetti et al., 1977). Even so, because
the long-term T cell cultures were initiated and maintained using
PHA-stimulated Ly-CM, the role played by the PHA vs. any puta-
tive growth factor was unclear. Also, because PHA was known to
activate polyclonal T cell proliferation, it was impossible to probe
for any antigen-speciﬁc functions to the cultured cells.
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CYTOLYTIC T LYMPHOCYTE LINES
At the time, we had already established systems using murine
splenocytes to generate CTL capable of lysing both allogeneic and
syngeneic leukemia cells (Gillis and Smith, 1977a). First, we found
that if we performed repetitive mixed tumor lymphocyte cultures
(MTLC),we could enhance the generation of CTL as much as 100-
fold. Then, with secondary but not primary allogeneic MTLC, it
was possible to generate short-term T cell growth and differentia-
tion to CTL capable of lysing both allogeneic as well as syngeneic
leukemia cells. To explain our results, we speculated that the strong
stimulation afforded by the histocompatibility antigens may have
produced an allogeneic effect factor (AEF), similar to that found
to enhance T–B cell interaction in the generation of AFCs (Amerd-
ing and Katz, 1974). We also postulated that by using allogeneic
leukemia cells as stimulators, we might generate several different
clones of cells, some reactive with alloantigens and some reactive
with syngeneic tumor-speciﬁc antigens. This interpretation was
compatible with the ﬁndings of Zinkernagel and Doherty, in that
presumably the tumor-speciﬁc antigen could be expressed either
as a part of the self MHC-encoded molecule, i.e., altered self, or
it could be distinct from the self MHC, requiring two TCRs for
recognition. However, the nature of the T cell antigen recognition
structure(s) was still an enigma.
Given the ﬁndings of Morgan and co-workers, we specu-
lated that it might be possible to create tumor antigen-speciﬁc
long-term cytolytic T cell cultures by the use of Ly-CM. Because
Concanavalin-A (Con-A) was known to be a better mitogen for
murine cells than PHA, we prepared Con-A T cell supernatants
(which later was referred to by some as CATSUP), and seeded CTL
derived from allogeneic repetitive MTLCs using friend leukemia
virus (FLV)-transformed leukemia cells, hoping that functional
CTL could be maintained with the Ly-CM. This was considered a
long shot, because the immunological dogma indicated that only
speciﬁc antigen would be able to promote T cell proliferation.
However, the very ﬁrst experiments worked beautifully, and the
ﬁrst antigen-speciﬁc, long-term CTL lines (CTLL) were created
(Gillis and Smith, 1977b).
At the time of this report, the CTLL had been in continuous
culture for 22 weeks, and their allogeneic as well as syngeneic
Tumor cell cytolytic activity had increased >10-fold. The cells
required Ly-CM derived from Con-A-stimulated normal spleno-
cytes, while fresh media + Con-A could not support long-term
growth, thereby suggesting that the Ly-CM contained an obliga-
tory growth factor. We speculated that one of the important issues
that could now be approached was the molecular nature of the
growth factor activity in the Ly-CM, using the long-term CTLL
as target cells in a bioassay. In addition, we also speculated that
these long-term CTLL might also be useful in adoptive therapy
for leukemias, since they were cytolytic for virus non-producer
leukemia cells, which were most analogous to human leukemia
cells.
THE T CELL GROWTH FACTOR BIOASSAY
Prior to the development of the CTLL, Torgny Fredrickson and
I had developed a microassay for quantifying erythropoietin
(EPO), using mouse fetal liver cells (FLC) as the target cells,
which are comprised of a large proportion of EPO-responsive
erythroid precursor cells (Fredrickson et al., 1977; Smith et al.,
1977). This assay was based on the fact that erythroid precur-
sor cells proliferate and differentiate into hemoglobin producing
cells under the inﬂuence of EPO. Thus, we found that EPO
exerted a concentration-dependent increase in tritiated thymi-
dine (3H-TdR) and radiolabeled iron (59Fe) incorporation into
erythroid precursor cells with a peak reaction detectable after
only 24 h of culture in microwells. The principles of the assay
were adapted from interferon bioassays, which routinely employed
doubling dilution titrations, and comparison of the 50% effective
concentrations (EC50) using probability analysis (probit analy-
sis; Jordan, 1972). The rapidity of this assay, requiring only an
overnight culture, together with the capacity to readily quan-
tify the EPO concentrations was novel at the time, and allowed
us to perform adsorption experiments with FLCs, which sug-
gested that EPO interacted with cells by means of cell surface
receptors.
Accordingly, once we had developed CTLL, it was natu-
ral to adapt the EPO microassay for the quantiﬁcation of the
growth factor in Ly-CM that was critical for the continuous
CTLL proliferation. The quantitative microassay that we devel-
oped was a ﬁrst for lymphokines activities, in that previous
bioassays had only scored the presence or absence of a partic-
ular activity (Gillis et al., 1978b). We coined the term T cell
growth factor (TCGF) to designate that this particular activity
was distinctive in its capacity to mediate the long-term growth of
the CTLL. The ability to quantify the TCGF activity allowed us
to perform experiments on the biological characteristics of this
activity for the ﬁrst time. For example, we found that TCGF
activity could be quantitatively depleted from Ly-CM by both
mitogen-stimulated lymphocytes and the CTLL. Moreover, only
T cell mitogens such as PHA and Con-A or alloantigens could
elicit TCGF activity, B cell mitogens such as LPS being inac-
tive in this regard. In addition, the removal of T cells from
splenocyte or PBMC populations markedly reduced their capac-
ity for production of TCGF activity. However, as we noted,
this did not rule out the involvement of other cells, especially
macrophages, in TCGF production. We noted that similar T cell
factors, such as those reported to enhance the generation of lym-
phoid blast cells, AFCs, or CTLs could very well be similar to
or identical with TCGF, but there was no way to distinguish
between these various activities. Thus, we closed our report
with, “It is our hope that the bioassay described in this report
will be of use in future experimentation to approach the isola-
tion, characterization, and puriﬁcation of TCGF and similar factors”
(Gillis et al., 1978b).
The new quantitative TCGF microassay was helpful imme-
diately in regard to whether the TCGF activity also had T cell
differentiative activity that facilitated the generation of CTL. In
a series of experiments we established unequivocally that “TCGF
ampliﬁes the generation of cytotoxic T cells. . ..Depletion of TCGF
from (allogeneic) MTLC depressed both the number and cytolytic
activity of cells generated, whereas addition of TCGF to MTLC
enhanced both of these parameters” (Baker et al., 1978). Just like
the EPO effect on FLCs, which leads to both the proliferation
of erythroid precursors as well as their differentiation to RBCs
monitored by the uptake of 59Fe into hemoglobin molecules,
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TCGF promoted both the proliferation and differentiation of CTL
progenitors.
The TCGF bioassay also allowed us to test Ly-CM derived from
various species. It was found that the mouse CTLL cells could
also be maintained in Ly-CM from rat and man, but human T
cells could not respond to mouse TCGF. Thus, we could use the
mouse CTLL bioassay to quantify the TCGF activity in human
Ly-CM, so that we could optimize human TCGF production. This
led us immediately to the creation of the ﬁrst long-term antigen-
speciﬁc human CTLLs (Gillis et al., 1978a). These hCTLL were
very similar, if not identical to the murine CTLL, so that these
experiments conﬁrmed our murine studies and by extending the
phenomenon to the human, they underscored the biological gen-
erality of the continuous culture of antigen-speciﬁc functional T
cells. These data also prompted us to predict that “Such cells will
undoubtedly prove useful for studies on the mechanism of LMC, and
for characterization of T cell antigen receptors and (other) T cell
surface markers.” We also speculated that human tumor-speciﬁc
CTLL might conceivably be used for adoptive immunotherapy
for cancer. In addition, it seemed reasonable to assume that it
should be possible to generate functional helper and putative
suppressor T cell lines, which “may provide a new means for the
study of both the mechanism and regulation of T cell mediated
immunity.”
Ia MOLECULES
At about this time, Benacerraf (1978) published an “Opinion”
article that galvanized and focused investigators perplexed by Ir
genes, Ia antigens and the nature of T cell antigen recognition.
First, he reiterated the characteristics of Ir genes in the I-regions of
the MHC of mammals, and proposed presciently the hypothesis
that perhaps the Ia molecules formed an immunogenic complex
together with peptide epitopes capable of stimulating T cells.
He summarized research indicating that T cells recognize epi-
topes comprised of short speciﬁc chains of three to four amino
acids, whereas antibodies often recognized epitopes formed by the
tertiary structures of native proteins. Also, he stressed the impor-
tance of macrophage processing and presentation for T-dependent
immune responses, a phenomenon that had been recognized and
studied for more than a decade (Unanue and Askonas, 1968). He
intentionally stated that his theory did not deﬁne the nature of
the T cell antigen receptors, nor the hypothesis that there could
be more than one receptor. In addition, he was careful to state
that his hypothesis was compatible with the Zinkernagel–Doherty
phenomenon where the K- and D-region encoded molecules were
postulated to interact with viral antigens in a manner similar to Ia
molecule–peptide interaction.
He also speciﬁcally stated that his hypothesis was not con-
cerned with antigen-speciﬁc helper and suppressor factors bearing
I-region-controlled determinants. In addition, he stressed that
according to his hypothesis, macrophage Ia molecules could bind
macrophage-processed fragments of autologous proteins, as well
as foreign proteins, and that speciﬁc unresponsiveness to autol-
ogous antigens could not depend upon the absence of Ia–self
peptide interactions, but rather must depend on speciﬁc unre-
sponsiveness at the T cell level by either an active or passive
mechanism.
Thus, Benacerraf crystallized his 20 years of work on the genetic
control of the T cell immune response. The Ir gene control speci-
ﬁed the curious nature of the antigens recognized by T cells, which
differedmarkedly from the nature of antigens recognized by B cells
and antibodies. Even so, the nature of MHC-encoded molecules,
the peptide–MHC interaction and the TCR still remained elusive,
including the one receptor vs. two receptor hypotheses.
CONCLUSION
The 20 years after Burnet proposed his clonal selection theorywere
taken up with the elucidation of the arm of the immune system
that was totally obscure in his time, that is the cellular arm, which
we now know as the T cell immune response. It’s discovery and
comparisons and contrasts with the humoral or B cell immune
response led to the uncovering of many surprising phenomena,
including that T cells “helped” B cells proliferate and differentiate
into AFCs, and also “suppressed” antibody formation. Moreover,
T cells themselves could proliferate and differentiate into“effector”
cells capable of actually killing target cells that they recognized as
foreign. Even more mysterious and surprising was the fact that
T cells “recognized” foreignness differently than did B cells and
antibodies, and even more surprising, both the T cell and B cell
immune responses depended upon the genetic constitution of the
host, somehow linked to the large gene locus that encodes histo-
compatibility. In addition, not only were there two distinct kinds
of lymphocytes, T cell subsets were recognized for the ﬁrst time.
All of these ﬁndings occurred as the science of immunology made
the transition from studies of whole animals and humans to the
study of cells in cultures. This transition led to the discovery of
additional lymphocyte products that were not antibodies, which
came to be known as lymphokines or cytokines. However, exactly
what these newly discovered molecules were, and how they ﬁg-
ured into the immune system remained obscure. Thus, by 1980
the burning questions of immunology focused on these issues, and
how could one reduce the complexity further, as well as how could
one reduce the science from cell populations to individual cells, to
molecules.
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